Filing Details

Accession Number:
0001140361-16-060243
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-04-05 16:08:23
Reporting Period:
2016-04-01
Filing Date:
2016-04-05
Accepted Time:
2016-04-05 16:08:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
881524 Vivus Inc VVUS Pharmaceutical Preparations (2834) 943136179
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1557543 North Tide Capital, Llc 500 Boylston Street
Suite 1860
Boston MA 02116
No No Yes No
1594068 Conan Laughlin 500 Boylston Street
Suite 1860
Boston MA 02116
No No Yes No
1594882 North Tide Capital Master, Lp 500 Boylston Street
Suite 1860
Boston MA 02116
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-04-01 2,160 $1.40 13,587,460 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Footnotes
  1. Shares reported herein represent: as of April 1, 2016, (i) 11,940,960 shares held by North Tide Capital Master, LP (the "Master Fund") and (ii) 1,646,500 shares held by a managed account (the "Account).
  2. Of the shares purchased on April 1, 2016 at a price of $1.4017 per share, 1,985 shares were held for the account of the Master Fund, 175 shares were held for the account of the Account. All of such shares may be deemed beneficially owned by North Tide and Mr. Laughlin.
  3. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.